Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB288912

EIF4EBP3 Antibody (OTI3B9), FITC, Novus Biologicals™
SDP

Catalog No. NB288912 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB288912 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB288912 Supplier Novus Biologicals Supplier No. NBP271383F
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

EIF4EBP3 Monoclonal antibody specifically detects EIF4EBP3 in Human samples. It is validated for Western Blot

Specifications

Antigen EIF4EBP3
Applications Western Blot
Classification Monoclonal
Clone OTI3B9
Conjugate FITC
Dilution Western Blot
Formulation PBS
Gene Alias eIF4E-binding protein 3, eukaryotic translation initiation factor 4E binding protein 3,4E-BP3eukaryotic initiation factor 4E-binding protein 3, eukaryotic translation initiation factor 4E-binding protein 3,4EBP3
Host Species Mouse
Immunogen Full length human recombinant protein of human EIF4EBP3 (NP_003723) produced in E.coli.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline DNA replication Transcription Translation and Splicing
Primary or Secondary Primary
Gene ID (Entrez) 8637
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.